LI
LifeWealth Investments, LLC
13F filer · CIK 0002033794Reported Jul 16, 2026
Net buyer this quarter
13F portfolio value$374MU.S. long equity reported on 13F
Positions6511 new · 6 closed
Net flow last quarter+$13.5MBuys minus sells
Top 10 positions weight22.8%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 16, 202665 positions | |||||
| $19.6M | 5.23% | 0.19% | +10.2% | Q1 2025 | |
| $12.7M | 3.40% | Not reported | +0.5% | Q4 2024 | |
| $11.5M | 3.06% | 0.00% | +2.8% | Q4 2024 | |
| $10.4M | 2.78% | 0.02% | +12.0% | Q4 2024 | |
| $7.29M | 1.95% | 0.00% | +1.7% | Q4 2024 | |
| $6.06M | 1.62% | Not reported | -1.8% | Q4 2024 | |
| $5.51M | 1.47% | Not reported | New | Q2 2026 | |
| $4.9M | 1.31% | 0.00% | -0.5% | Q4 2024 | |
| $3.74M | 1.00% | 0.00% | +1.1% | Q4 2024 | |
| $3.64M | 0.97% | 0.00% | +1.0% | Q4 2024 | |
| $2.43M | 0.65% | Not reported | Not reported | Q4 2024 | |
| $2.31M | 0.62% | 0.00% | +22.7% | Q4 2024 | |
| OBONEZOne Bio, Corp. | $2.13M | 0.57% | Not reported | +105.3% | Q1 2025 |
| $1.94M | 0.52% | 0.00% | -0.9% | Q4 2024 | |
| $1.77M | 0.47% | Not reported | Not reported | Q4 2024 | |
| $1.61M | 0.43% | 0.00% | -0.2% | Q4 2024 | |
| $1.45M | 0.39% | Not reported | -7.8% | Q4 2024 | |
| $1.45M | 0.39% | Not reported | -2.3% | Q4 2024 | |
| $1.31M | 0.35% | 0.00% | +4.0% | Q4 2024 | |
| $1.07M | 0.29% | 0.00% | +1.8% | Q2 2025 | |
| $921K | 0.25% | 0.00% | +1.2% | Q4 2024 | |
| $817K | 0.22% | 0.00% | -6.0% | Q4 2024 | |
| $749K | 0.20% | 0.00% | +1.7% | Q4 2024 | |
| $715K | 0.19% | 0.00% | +1.9% | Q1 2025 | |
| $709K | 0.19% | 0.00% | +1.7% | Q1 2025 | |
| $641K | 0.17% | 0.00% | +1.4% | Q4 2024 | |
| $550K | 0.15% | 0.00% | -5.0% | Q3 2025 | |
| $543K | 0.15% | 0.00% | New | Q2 2026 | |
| $541K | 0.14% | 0.00% | New | Q2 2026 | |
| $536K | 0.14% | 0.00% | +9.5% | Q2 2025 | |
| $532K | 0.14% | 0.00% | -6.0% | Q1 2026 | |
| $486K | 0.13% | Not reported | +27.4% | Q2 2025 | |
| $484K | 0.13% | Not reported | -24.6% | Q1 2026 | |
| $477K | 0.13% | Not reported | Not reported | Q4 2024 | |
| $459K | 0.12% | 0.00% | +0.3% | Q1 2026 | |
| $442K | 0.12% | 0.00% | +67.5% | Q2 2025 | |
| $440K | 0.12% | 0.00% | +1.0% | Q2 2025 | |
| $434K | 0.12% | 0.00% | +11.0% | Q1 2025 | |
| $422K | 0.11% | 0.00% | +35.7% | Q4 2024 | |
| $413K | 0.11% | 0.00% | -10.7% | Q4 2024 | |
| $406K | 0.11% | 0.00% | +2.2% | Q4 2024 | |
| $368K | 0.10% | 0.00% | +0.5% | Q4 2024 | |
| $348K | 0.09% | Not reported | +12.6% | Q4 2024 | |
| $342K | 0.09% | 0.00% | +0.6% | Q4 2024 | |
| $319K | 0.09% | 0.00% | +10.5% | Q1 2025 | |
| $315K | 0.08% | 0.00% | -0.1% | Q4 2024 | |
| $301K | 0.08% | 0.00% | +4.1% | Q4 2024 | |
| $299K | 0.08% | 0.00% | New | Q2 2026 | |
| $296K | 0.08% | 0.00% | -10.0% | Q4 2024 | |
| $293K | 0.08% | 0.00% | +7.0% | Q4 2024 | |
| Q1 2026Reported Apr 21, 202659 positions | |||||
| $16.6M | 4.97% | 0.17% | +26.2% | Q1 2025 | |
| $11.2M | 3.34% | Not reported | +15.5% | Q4 2024 | |
| $10.9M | 3.24% | 0.01% | +9.5% | Q4 2024 | |
| $9.78M | 2.92% | 0.00% | +1.6% | Q4 2024 | |
| $6.32M | 1.89% | Not reported | +10.2% | Q4 2024 | |
| $6.25M | 1.87% | 0.00% | +5.7% | Q4 2024 | |
| $4.3M | 1.28% | 0.00% | +1.4% | Q4 2024 | |
| $3.68M | 1.10% | 0.00% | -1.2% | Q4 2024 | |
| $2.9M | 0.87% | 0.00% | +5.2% | Q4 2024 | |
| $1.77M | 0.53% | Not reported | Not reported | Q4 2024 | |
| $1.73M | 0.52% | 0.00% | +1.7% | Q4 2024 | |
| $1.6M | 0.48% | 0.00% | -69.6% | Q4 2024 | |
| $1.6M | 0.48% | Not reported | +1.7% | Q4 2024 | |
| $1.55M | 0.46% | 0.00% | -4.3% | Q4 2024 | |
| $1.43M | 0.43% | 0.00% | 0.0% | Q4 2024 | |
| $1.2M | 0.36% | Not reported | -7.3% | Q4 2024 | |
| OBONEZOne Bio, Corp. | $941K | 0.28% | Not reported | -25.3% | Q1 2025 |
| $856K | 0.26% | 0.00% | -2.0% | Q4 2024 | |
| $785K | 0.23% | 0.00% | -15.1% | Q4 2024 | |
| $757K | 0.23% | 0.00% | +8.8% | Q2 2025 | |
| $698K | 0.21% | 0.00% | +5.4% | Q4 2024 | |
| $665K | 0.20% | 0.00% | +7.5% | Q1 2025 | |
| $583K | 0.17% | 0.00% | +11.5% | Q1 2025 | |
| $561K | 0.17% | Not reported | New | Q1 2026 | |
| $558K | 0.17% | 0.00% | -0.3% | Q4 2024 | |
| $557K | 0.17% | 0.00% | +2.9% | Q4 2024 | |
| $537K | 0.16% | 0.00% | -0.7% | Q2 2025 | |
| $533K | 0.16% | 0.00% | +12.7% | Q1 2025 | |
| $532K | 0.16% | 0.00% | +1.5% | Q4 2024 | |
| $463K | 0.14% | 0.00% | -0.6% | Q4 2024 | |
| $400K | 0.12% | 0.00% | New | Q1 2026 | |
| $388K | 0.12% | 0.00% | +1.0% | Q4 2024 | |
| $388K | 0.12% | 0.00% | +7.6% | Q2 2025 | |
| $386K | 0.12% | 0.00% | +5.0% | Q4 2024 | |
| $386K | 0.12% | 0.00% | New | Q1 2026 | |
| $381K | 0.11% | Not reported | +10.2% | Q4 2024 | |
| $368K | 0.11% | 0.00% | -61.5% | Q4 2024 | |
| $362K | 0.11% | 0.00% | +3.9% | Q1 2025 | |
| $358K | 0.11% | 0.00% | +0.1% | Q4 2024 | |
| $338K | 0.10% | 0.00% | -22.5% | Q1 2025 | |
| $317K | 0.09% | 0.00% | -41.3% | Q4 2024 | |
| $299K | 0.09% | Not reported | -24.8% | Q2 2025 | |
| $296K | 0.09% | Not reported | -12.1% | Q4 2024 | |
| $289K | 0.09% | 0.00% | +42.2% | Q1 2025 | |
| $285K | 0.09% | 0.00% | +6.5% | Q3 2025 | |
| $281K | 0.08% | 0.00% | +15.3% | Q4 2025 | |
| $279K | 0.08% | 0.00% | -1.3% | Q2 2025 | |
| $272K | 0.08% | 0.00% | -3.0% | Q2 2025 | |
| $268K | 0.08% | 0.00% | New | Q1 2026 | |
| $265K | 0.08% | 0.00% | +1.7% | Q2 2025 | |
| Q4 2025Reported Jan 26, 202662 positions | |||||
| $13.3M | 4.21% | 0.14% | -42.9% | Q1 2025 | |
| $10.3M | 3.27% | 0.00% | -53.0% | Q4 2024 | |
| $9.39M | 2.97% | Not reported | -45.6% | Q4 2024 | |
| $9.13M | 2.89% | 0.01% | -52.1% | Q4 2024 | |
| $6.33M | 2.00% | 0.00% | -72.9% | Q4 2024 | |
| $5.94M | 1.88% | Not reported | -48.2% | Q4 2024 | |
| $4.98M | 1.58% | 0.01% | -57.1% | Q4 2024 | |
| $4.86M | 1.54% | 0.00% | -53.1% | Q4 2024 | |
| $4.7M | 1.49% | 0.00% | -54.7% | Q4 2024 | |
| $3M | 0.95% | 0.00% | -57.0% | Q4 2024 | |
| $2.06M | 0.65% | 0.00% | -52.3% | Q4 2024 | |
| $1.82M | 0.58% | Not reported | -55.7% | Q4 2024 | |
| $1.81M | 0.57% | 0.00% | -52.3% | Q4 2024 | |
| $1.77M | 0.56% | Not reported | -50.0% | Q4 2024 | |
| $1.42M | 0.45% | Not reported | -52.1% | Q4 2024 | |
| $1.35M | 0.43% | 0.00% | -77.3% | Q4 2024 | |
| OBONEZOne Bio, Corp. | $1.31M | 0.41% | Not reported | -52.8% | Q1 2025 |
| $867K | 0.27% | 0.00% | -58.2% | Q4 2024 | |
| $800K | 0.25% | 0.00% | -52.2% | Q4 2024 | |
| $774K | 0.25% | 0.00% | -52.3% | Q4 2024 | |
| $766K | 0.24% | 0.00% | -52.9% | Q4 2024 | |
| $744K | 0.24% | 0.00% | -49.3% | Q2 2025 | |
| $678K | 0.21% | Not reported | -51.8% | Q4 2024 | |
| $628K | 0.20% | 0.00% | -59.9% | Q4 2024 | |
| $564K | 0.18% | 0.00% | -61.0% | Q4 2024 | |
| $550K | 0.17% | 0.00% | -63.1% | Q4 2024 | |
| $543K | 0.17% | 0.00% | -56.3% | Q1 2025 | |
| $534K | 0.17% | Not reported | -49.4% | Q4 2024 | |
| $513K | 0.16% | 0.00% | -59.6% | Q1 2025 | |
| $510K | 0.16% | 0.00% | -72.7% | Q4 2024 | |
| $504K | 0.16% | 0.00% | -50.0% | Q4 2024 | |
| $484K | 0.15% | 0.00% | -41.0% | Q2 2025 | |
| $469K | 0.15% | 0.00% | -50.5% | Q1 2025 | |
| $459K | 0.15% | 0.00% | -42.5% | Q1 2025 | |
| $455K | 0.14% | 0.00% | -56.1% | Q4 2024 | |
| $423K | 0.13% | 0.00% | -66.0% | Q1 2025 | |
| $423K | 0.13% | Not reported | -44.2% | Q2 2025 | |
| $420K | 0.13% | 0.00% | -58.8% | Q4 2024 | |
| $397K | 0.13% | 0.00% | -64.3% | Q4 2024 | |
| $359K | 0.11% | Not reported | -50.0% | Q4 2024 | |
| $357K | 0.11% | 0.00% | New | Q4 2025 | |
| $353K | 0.11% | Not reported | -57.4% | Q4 2024 | |
| $345K | 0.11% | 0.00% | -58.4% | Q2 2025 | |
| $344K | 0.11% | 0.00% | -57.5% | Q4 2024 | |
| $332K | 0.11% | 0.00% | -64.6% | Q4 2024 | |
| $331K | 0.10% | 0.00% | -48.8% | Q2 2025 | |
| $299K | 0.09% | 0.00% | -50.6% | Q2 2025 | |
| $290K | 0.09% | 0.00% | -50.3% | Q4 2024 | |
| $278K | 0.09% | 0.00% | -50.6% | Q3 2025 | |
| $276K | 0.09% | 0.00% | New | Q4 2025 | |
| Q3 2025Reported Jan 26, 2026121 positions | |||||
| $22.8M | 3.48% | 0.24% | +2.9% | Q1 2025 | |
| $20.6M | 3.14% | 0.00% | -4.1% | Q4 2024 | |
| $20.3M | 3.11% | 0.00% | +36.1% | Q4 2024 | |
| $17.1M | 2.61% | Not reported | +8.1% | Q4 2024 | |
| $17.1M | 2.61% | 0.03% | +1.0% | Q4 2024 | |
| $12.8M | 1.96% | Not reported | +0.6% | Q4 2024 | |
| $11.1M | 1.69% | 0.00% | +18.7% | Q4 2024 | |
| $9.86M | 1.51% | 0.00% | +157.6% | Q4 2024 | |
| $7.63M | 1.16% | 0.03% | +0.6% | Q4 2024 | |
| $5.42M | 0.83% | 0.00% | +0.9% | Q4 2024 | |
| $4.56M | 0.70% | Not reported | +3.5% | Q4 2024 | |
| $4.28M | 0.65% | 0.01% | +21.1% | Q4 2024 | |
| $4.27M | 0.65% | 0.00% | -0.6% | Q4 2024 | |
| $3.61M | 0.55% | 0.00% | +4.8% | Q4 2024 | |
| $3.55M | 0.54% | Not reported | Not reported | Q4 2024 | |
| $3.17M | 0.48% | Not reported | +2.9% | Q1 2025 | |
| OBONEZOne Bio, Corp. | $2.83M | 0.43% | Not reported | +79.0% | Q1 2025 |
| $2.39M | 0.37% | 0.00% | +2.1% | Q4 2024 | |
| $2.3M | 0.35% | Not reported | +2.2% | Q4 2024 | |
| $2.22M | 0.34% | 0.00% | +0.7% | Q4 2024 | |
| $1.8M | 0.27% | 0.00% | +47.3% | Q4 2024 | |
| $1.7M | 0.26% | 0.00% | +51.4% | Q4 2024 | |
| $1.68M | 0.26% | 0.00% | +10.3% | Q4 2024 | |
| $1.53M | 0.23% | 0.00% | -4.3% | Q4 2024 | |
| $1.5M | 0.23% | 0.00% | -9.0% | Q4 2024 | |
| $1.38M | 0.21% | Not reported | +1.3% | Q4 2024 | |
| $1.34M | 0.20% | 0.00% | +56.7% | Q2 2025 | |
| $1.28M | 0.20% | 0.00% | +1.6% | Q1 2025 | |
| $1.24M | 0.19% | 0.00% | +10.0% | Q1 2025 | |
| $1.2M | 0.18% | 0.00% | -7.7% | Q2 2025 | |
| $1.15M | 0.18% | 0.00% | +1.7% | Q4 2024 | |
| $1.13M | 0.17% | 0.00% | +5.9% | Q1 2025 | |
| $1.08M | 0.16% | Not reported | +2.6% | Q4 2024 | |
| $1.04M | 0.16% | 0.00% | -5.2% | Q4 2024 | |
| $1.03M | 0.16% | 0.00% | -0.9% | Q4 2024 | |
| $1.02M | 0.16% | 0.00% | +1.5% | Q4 2024 | |
| $991K | 0.15% | 0.00% | +0.8% | Q4 2024 | |
| $988K | 0.15% | 0.00% | -0.9% | Q4 2024 | |
| $970K | 0.15% | 0.00% | +1.9% | Q1 2025 | |
| $898K | 0.14% | 0.00% | -5.0% | Q4 2024 | |
| $882K | 0.13% | 0.00% | 0.0% | Q4 2024 | |
| $827K | 0.13% | Not reported | -10.7% | Q4 2024 | |
| $809K | 0.12% | 0.00% | +2.5% | Q1 2025 | |
| $795K | 0.12% | 0.00% | +3.6% | Q4 2024 | |
| $779K | 0.12% | 0.00% | +8.1% | Q4 2024 | |
| $760K | 0.12% | 0.00% | +12.4% | Q2 2025 | |
| $750K | 0.11% | 0.00% | +3.0% | Q4 2024 | |
| $741K | 0.11% | Not reported | +3.0% | Q2 2025 | |
| $724K | 0.11% | 0.00% | -3.0% | Q4 2024 | |
| $722K | 0.11% | 0.00% | +0.5% | Q4 2024 | |
Premium opens every quarter this fund has filed